Methods and systems for processing polynucleotides

US12534760B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12534760-B2
Application numberUS-202519083328-A
CountryUS
Kind codeB2
Filing dateMar 18, 2025
Priority dateDec 22, 2016
Publication dateJan 27, 2026
Grant dateJan 27, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing and analyte characterization. Such polynucleotide processing may be useful for a variety of applications, including analyte characterization by polynucleotide sequencing. The compositions, methods, systems, and devices disclosed herein generally describe barcoded oligonucleotides, which can be bound to a bead, such as a gel bead, useful for characterizing one or more analytes including, for example, protein (e.g., cell surface or intracellular proteins), genomic DNA, and RNA (e.g., mRNA or CRISPR guide RNAs). Also described herein, are barcoded labelling agents and oligonucleotide molecules useful for “tagging” analytes for characterization.

First claim

Opening claim text (preview).

What is claimed is: 1 . A composition comprising: a partition comprising a plurality of barcode molecules, wherein the plurality of barcode molecules comprises: (a) a first barcode molecule comprising a nucleic acid barcode sequence, wherein the first barcode molecule is hybridized to a first analyte, wherein the first analyte is not messenger ribonucleic acid (mRNA) and is not hybridized to the first barcode molecule via a poly-thymine (poly-T) sequence, wherein the first analyte comprises clustered regularly interspaced short palindromic repeat (CRISPR) ribonucleic acid (crRNA) or single guide ribonucleic acid (sgRNA); and (b) a second barcode molecule comprising the nucleic acid barcode sequence, wherein the second barcode molecule is hybridized to a second analyte, wherein the second analyte is mRNA and is hybridized to the second barcode molecule via a poly-T sequence. 2 . The composition of claim 1 , wherein barcode molecules of the plurality of barcode molecules are attached to a bead. 3 . The composition of claim 2 , wherein the bead is a gel bead. 4 . The composition of claim 2 , wherein the bead comprises polyacrylamide. 5 . The composition of claim 2 , wherein barcode molecules of the plurality of barcode molecules are releasably attached to the bead. 6 . The composition of claim 1 , wherein the partition is a partition among a plurality of partitions. 7 . The composition of claim 6 , wherein the plurality of partitions comprises at least about 1,000; 5,000; 10,000; 50,000; 100,000; 500,000; 1,000,000; 5,000,000; 10,000,000; 50,000,000; 100,000,000, 500,000,000; or 1,000,000,000 partitions. 8 . The composition of claim 6 , wherein the partition is a droplet, and the plurality of partitions is a plurality of droplets. 9 . The composition of claim 6 , wherein the partition is a well, and the plurality of partitions is a plurality of wells. 10 . The composition of claim 1 , wherein the first barcode molecule and the second barcode molecule further comprise a random N-mer sequence. 11 . A composition comprising: a plurality of droplets, wherein a droplet of the plurality of droplets comprises: a gel bead having a plurality of barcode molecules attached thereto, wherein the plurality of barcode molecules comprises: (a) a first barcode molecule comprising a nucleic acid barcode sequence, wherein the first barcode molecule is hybridized to a first analyte, wherein the first analyte is not mRNA and is not hybridized to the first barcode molecule via a poly-T sequence, wherein the first analyte comprises a clustered regularly interspaced short palindromic repeat (CRISPR) ribonucleic acid (crRNA) or a single guide ribonucleic acid (sgRNA); and (b) a second barcode molecule comprising the nucleic acid barcode sequence, wherein the second barcode molecule is hybridized to a second analyte, wherein the second analyte is mRNA and is hybridized to the second barcode molecule via a poly-T sequence, wherein the first barcode molecule and the second barcode molecule further comprise a random N-mer sequence. 12 . A composition comprising: a partition comprising a bead having a plurality of barcode molecules attached thereto, wherein the plurality of barcode molecules comprises: (a) a first population of barcode molecules each hybridized to mRNA via poly-T sequences, wherein barcode molecules of the first population of barcode molecules each comprise a barcode sequence and a random sequence; and (b) a second population of barcode molecules each hybridized to an analyte comprising a clustered regularly interspaced short palindromic repeat (CRISPR) ribonucleic acid (crRNA) or a single guide ribonucleic acid (sgRNA) via a sequence that is not poly-T, wherein barcode molecules of the second population of barcode molecules each comprise a barcode sequence and a random sequence; wherein barcode sequences are constant among the plurality of barcode molecules and random sequences vary among the plurality of barcode molecules. 13 . The composition of claim 12 , wherein the bead is a gel bead. 14 . The composition of claim 12 , wherein the bead comprises polyacrylamide. 15 . The composition of claim 12 , wherein the partition is a partition among a plurality of partitions. 16 . The composition of claim 15 , wherein the plurality of partitions comprises at least about 1,000; 5,000; 10,000; 50,000; 100,000; 500,000; 1,000,000: 5,000,000; 10,000,000; 50,000,000; 100,000,000, 500,000,000; or 1,000,000,000 partitions. 17 . The composition of claim 15 , wherein the partition is a droplet, and the plurality of partitions is a plurality of droplets. 18 . The composition of claim 15 , wherein the partition is a well, and the plurality of partitions is a plurality of wells. 19 . The composition of claim 11 , wherein the bead comprises polyacrylamide. 20 . The composition of claim 11 , wherein the plurality of droplets comprises at least about 1,000; 5,000; 10,000; 50,000; 100,000; 500,000; 1,000,000; 5,000,000; 10,000,000; 50,000,000; 100,000,000; 500,000,000; or 1,000,000,000 droplets.

Assignees

Inventors

Classifications

  • the label being a nucleic acid · CPC title

  • Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis · CPC title

  • incorporating an adaptor · CPC title

  • involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP] · CPC title

  • C12Q1/6806Primary

    Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12534760B2 cover?
The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing and analyte characterization. Such polynucleotide processing may be useful for a variety of applications, including analyte characterization by polynucleotide sequencing. The compositions, methods, systems, and devices disclosed herein generally describe barcoded oligonucleotides, which can…
Who is the assignee on this patent?
10X Genomics Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6806. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).